About: Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $9.49 (-1.56%)
IMMX NASDAQ Immix Biopharma Inc
Carregando status da lista de acompanhamento…
Immix Biopharma Inc share price
IMMX price activity
Último preço
$ 9,490
Variação (24h)
-0,15 USD (-1,56%)
Volume
137.89K
Volume (média 4 sem.)
-
Abertura
$ 9,50
Variação do dia
$ 9,40 - $ 9,67
Fechamento anterior
$ 9,64
Último negócio
07 Oct, 2:35 pm GMT+0
Atrasado
07 Oct, 2:35 pm GMT+0
IMMX price performance
-8,79%
5D
-31,78%
1M
81,45%
YTD
278,09%
1Y
Atrasado
07 Oct, 2:35 pm GMT+0
quote.marketSignals